A focused, clinically oriented update across solid tumors and hematologic malignancies. Expert, case-based lectures convert new evidence and guidelines into clear diagnostic pathways, treatment algorithms, and toxicity-management plans you can put to work immediately in clinic, infusion, and inpatient settings.
What You Will Learn
How to incorporate current screening, staging, and biomarker guidance into everyday decisions
Practical selection and sequencing of chemotherapy, targeted agents, and immunotherapies
Recognition and management of immune-related and targeted-therapy adverse events
Multidisciplinary strategies for supportive care, survivorship, and palliative integration
Communication pearls for shared decision-making and goal-concordant care
Event Details
Format: Live, case-based lectures with panel Q&A and concise take-home checklists
Structure: Disease-site blocks plus cross-cutting sessions on genomics, toxicity, and supportive care
Access: Designed for rapid implementation in community and academic practice
Who Should AttendMedical oncologists, hematologist-oncologists, surgeons, radiation oncologists, hospitalists, advanced practice providers, oncology pharmacists, nurses, and fellows/trainees seeking a high-yield, practice-ready update.
Why Attend
Translate complex trials and guidelines into simple, usable algorithms
Update diagnostic and therapeutic strategies across high-prevalence cancers
Improve safety, efficiency, and patient experience with ready-to-use tools and checklists
+ Topics:
Agenda.pdf





Reviews
There are no reviews yet.